Table 1.

Univariable and multivariable logistic regression models evaluating the relationship between patient characteristics and the development of complicated COVID-19 disease

CharacteristicUnivariable OR95% CIP valueMultivariable OR95% CIP value
Sex, M/F2.411.80–3.24<0.00012.011.46–2.77<0.0001
Age, <65/≥652.441.81–3.28<0.00011.901.37–2.65<0.0001
Comorbidities, 0–1/≥22.471.83–3.35<0.00011.751.24–2.460.001
Tumor stage, nonadvanced/advanced0.840.62–1.120.231.240.85–1.810.26
Tumor status0.670.49–0.920.0120.690.46–1.030.07
 Remission/no measurable disease
 Active malignancy
Anticancer therapy, no/yes0.520.39–0.70<0.00010.680.48–1.00P = 0.03
Immunotherapy ongoing, no/yes1.120.59–2.140.73
Chemotherapy ongoing, no/yes1.150.78–1.680.47
Targeted therapy ongoing, no/yes0.650.40–1.050.08